3631 results for «438»

Filter By

3631 results

TAVI and future coronary access - LIVE case

18 Feb 2024 – From PCR Tokyo Valves 2024

An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...

TAVI and future coronary access - LIVE case

TAV-in-TAV interventions: a new frontier in TAVI

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore the distinctions between TAV-in-TAV and TAV-in-SAV, learn more about the challenges posed by heterogeneity and variability in TAV redo procedures, gain insights into the unified terminology of TAV designs, and uncover how step-by-step CT analysis facilitates comprehensive assessments and post Redo-TAV solutions, drawing from detailed...

TAV-in-TAV interventions:

Late-Breaking Trial session

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...

Late-Breaking Trial session

Heart Team in action: managing complex cases together

17 Feb 2024 – From PCR Tokyo Valves 2024

In this group discussion, several heart teams present their work on complex cases of tricuspid valve interventions and explore the results of their collaboration in order to figure out adequate management for invasive treatments. 

PCR Tokyo Valves 2024 Closing Ceremony

18 Feb 2024 – From PCR Tokyo Valves 2024

The closing ceremony of this 2024 edition of PCR Tokyo Valves is an opportunity to present the finalists and then to award the prizes to the winners of the best clinical case and best scientific abstract, before thanking all those involved in making the 3-day Course...

PCR Tokyo Valves 2024

Best clinical cases: Stent degloving, valve defects, and calcified lesions

04 Oct 2024 – From AICT-AsiaPCR 2024

Immerse yourself in a captivating collection of best clinical cases from AICT-AsiaPCR 2024. Witness the ingenuity and expertise of interventional cardiologists as they navigate complex scenarios, from addressing stuck prosthetic mitral valves to managing unconventional calcified lesions. Discover unique approaches, innovative solutions, and valuable lessons that...

Best clinical cases: Stent degloving, valve defects, and calcified lesions

Expert strategies for high-risk left main procedures

04 Oct 2024 – From AICT-AsiaPCR 2024

Expert strategies for high-risk left main procedures

EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency

04 Nov 2021

Elad Asher reviews the EROSION III trial, presented by Haibo Jia, which studied whether OCT guidance compared with angiographic guidance only is associated with lower stent rate implantation during pPCI in STEMI patients with non-obstructive stenosis.

Elad Asher

Author

Elad Asher
EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD

Insights from the Corevalve US Pivotal and SURTAVI trials

05 Apr 2022

Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.

Pierre Deharo

Author

Pierre Deharo
Giuseppe Di Gioia

Author

Giuseppe Di Gioia
Insights From the Corevalve US Pivotal and SURTAVI Trials

Top Interventional Trials presented at ACC.21

07 Jun 2021

Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21

Author

Ali Nazmi Calik
Top Interventional Trials presented at ACC.21
Didn’t find what you were looking for?